학술논문
Short and intermediate-term clinical outcomes in infants treated with 0.5 mg and 0.625 mg intravitreal bevacizumab for vision-threatening retinopathy of prematurity
Document Type
Abstract
Author
Source
In Journal of AAPOS August 2015 19(4):e56-e56
Subject
Language
ISSN
1091-8531